US Stock MarketDetailed Quotes

LUMO Lumos Pharma (Delisted)

Watchlist
  • 4.340
  • 0.0000.00%
Close Dec 11 16:00 ET
37.54MMarket Cap-1.01P/E (TTM)

Lumos Pharma (Delisted) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
10,271.43%726K
-7.40%488K
-76.12%165K
34.67%2.05M
61.33%826K
-98.59%7K
2.53%527K
522.52%691K
562.17%1.52M
132.73%512K
Operating revenue
10,271.43%726K
-7.40%488K
-76.12%165K
34.67%2.05M
61.33%826K
-98.59%7K
2.53%527K
522.52%691K
562.17%1.52M
132.73%512K
Cost of revenue
Gross profit
Operating expense
-6.41%8.37M
-18.28%8.31M
26.37%11.03M
15.20%38.67M
15.87%10.83M
11.08%8.94M
-37.10%10.17M
11.27%8.73M
6.29%33.56M
37.68%9.35M
Selling and administrative expenses
8.22%4.21M
-11.19%3.68M
-13.27%3.78M
5.49%16.57M
-6.96%4.17M
-0.64%3.89M
-43.23%4.15M
20.33%4.36M
2.45%15.71M
30.83%4.49M
-General and administrative expense
8.22%4.21M
-11.19%3.68M
-13.27%3.78M
5.49%16.57M
-6.96%4.17M
-0.64%3.89M
-43.23%4.15M
20.33%4.36M
2.45%15.71M
30.83%4.49M
Research and development costs
-17.70%4.15M
-23.16%4.63M
65.90%7.25M
23.74%22.1M
36.92%6.66M
22.21%5.05M
-32.06%6.02M
3.51%4.37M
9.92%17.86M
44.66%4.86M
Operating profit
14.46%-7.64M
18.87%-7.82M
-35.18%-10.86M
-14.28%-36.61M
-13.23%-10M
-18.30%-8.93M
38.40%-9.64M
-3.93%-8.04M
-2.21%-32.04M
-34.50%-8.84M
Net non-operating interest income expense
-62.33%168K
-87.48%70K
-72.28%158K
113.73%1.87M
-41.75%293K
52.74%446K
607.59%559K
11,300.00%570K
7,183.33%874K
1,097.62%503K
Non-operating interest income
-62.33%168K
-87.48%70K
-72.28%158K
113.73%1.87M
-41.75%293K
52.74%446K
607.59%559K
11,300.00%570K
7,183.33%874K
9,960.00%503K
Other net income (expense)
-97.31%5K
62.90%202K
121.01%263K
650.55%683K
252.78%254K
2,557.14%186K
933.33%124K
1,883.33%119K
-66.17%91K
-71.20%72K
Other non- operating income (expenses)
-97.31%5K
62.90%202K
121.01%263K
650.55%683K
252.78%254K
2,557.14%186K
933.33%124K
1,883.33%119K
-66.17%91K
-71.20%72K
Income before tax
10.04%-7.47M
15.73%-7.55M
-42.13%-10.44M
-9.62%-34.06M
-14.49%-9.46M
-14.47%-8.3M
42.43%-8.96M
4.84%-7.35M
-0.03%-31.08M
-31.59%-8.26M
Income tax
0
0
-123.08%-29K
0
0
-29K
97.96%-13K
-13K
Net income
10.04%-7.47M
15.45%-7.55M
-42.13%-10.44M
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
42.62%-8.93M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
Net income continuous Operations
10.04%-7.47M
15.45%-7.55M
-42.13%-10.44M
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
42.62%-8.93M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
Minority interest income
Net income attributable to the parent company
10.04%-7.47M
15.45%-7.55M
-42.13%-10.44M
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
42.62%-8.93M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
10.04%-7.47M
15.45%-7.55M
-42.13%-10.44M
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
42.62%-8.93M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
Basic earnings per share
13.46%-0.9
14.68%-0.93
-44.94%-1.29
-12.67%-4.18
-19.39%-1.17
-20.93%-1.04
41.40%-1.09
3.26%-0.89
-1.64%-3.71
-44.12%-0.98
Diluted earnings per share
13.46%-0.9
14.68%-0.93
-44.94%-1.29
-12.67%-4.18
-19.39%-1.17
-20.93%-1.04
41.40%-1.09
3.26%-0.89
-1.64%-3.71
-44.12%-0.98
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 10,271.43%726K-7.40%488K-76.12%165K34.67%2.05M61.33%826K-98.59%7K2.53%527K522.52%691K562.17%1.52M132.73%512K
Operating revenue 10,271.43%726K-7.40%488K-76.12%165K34.67%2.05M61.33%826K-98.59%7K2.53%527K522.52%691K562.17%1.52M132.73%512K
Cost of revenue
Gross profit
Operating expense -6.41%8.37M-18.28%8.31M26.37%11.03M15.20%38.67M15.87%10.83M11.08%8.94M-37.10%10.17M11.27%8.73M6.29%33.56M37.68%9.35M
Selling and administrative expenses 8.22%4.21M-11.19%3.68M-13.27%3.78M5.49%16.57M-6.96%4.17M-0.64%3.89M-43.23%4.15M20.33%4.36M2.45%15.71M30.83%4.49M
-General and administrative expense 8.22%4.21M-11.19%3.68M-13.27%3.78M5.49%16.57M-6.96%4.17M-0.64%3.89M-43.23%4.15M20.33%4.36M2.45%15.71M30.83%4.49M
Research and development costs -17.70%4.15M-23.16%4.63M65.90%7.25M23.74%22.1M36.92%6.66M22.21%5.05M-32.06%6.02M3.51%4.37M9.92%17.86M44.66%4.86M
Operating profit 14.46%-7.64M18.87%-7.82M-35.18%-10.86M-14.28%-36.61M-13.23%-10M-18.30%-8.93M38.40%-9.64M-3.93%-8.04M-2.21%-32.04M-34.50%-8.84M
Net non-operating interest income expense -62.33%168K-87.48%70K-72.28%158K113.73%1.87M-41.75%293K52.74%446K607.59%559K11,300.00%570K7,183.33%874K1,097.62%503K
Non-operating interest income -62.33%168K-87.48%70K-72.28%158K113.73%1.87M-41.75%293K52.74%446K607.59%559K11,300.00%570K7,183.33%874K9,960.00%503K
Other net income (expense) -97.31%5K62.90%202K121.01%263K650.55%683K252.78%254K2,557.14%186K933.33%124K1,883.33%119K-66.17%91K-71.20%72K
Other non- operating income (expenses) -97.31%5K62.90%202K121.01%263K650.55%683K252.78%254K2,557.14%186K933.33%124K1,883.33%119K-66.17%91K-71.20%72K
Income before tax 10.04%-7.47M15.73%-7.55M-42.13%-10.44M-9.62%-34.06M-14.49%-9.46M-14.47%-8.3M42.43%-8.96M4.84%-7.35M-0.03%-31.08M-31.59%-8.26M
Income tax 00-123.08%-29K00-29K97.96%-13K-13K
Net income 10.04%-7.47M15.45%-7.55M-42.13%-10.44M-9.57%-34.03M-14.67%-9.46M-14.47%-8.3M42.62%-8.93M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M
Net income continuous Operations 10.04%-7.47M15.45%-7.55M-42.13%-10.44M-9.57%-34.03M-14.67%-9.46M-14.47%-8.3M42.62%-8.93M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M
Minority interest income
Net income attributable to the parent company 10.04%-7.47M15.45%-7.55M-42.13%-10.44M-9.57%-34.03M-14.67%-9.46M-14.47%-8.3M42.62%-8.93M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 10.04%-7.47M15.45%-7.55M-42.13%-10.44M-9.57%-34.03M-14.67%-9.46M-14.47%-8.3M42.62%-8.93M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M
Basic earnings per share 13.46%-0.914.68%-0.93-44.94%-1.29-12.67%-4.18-19.39%-1.17-20.93%-1.0441.40%-1.093.26%-0.89-1.64%-3.71-44.12%-0.98
Diluted earnings per share 13.46%-0.914.68%-0.93-44.94%-1.29-12.67%-4.18-19.39%-1.17-20.93%-1.0441.40%-1.093.26%-0.89-1.64%-3.71-44.12%-0.98
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List